Heritage Cannabis Holdings' Subsidiary PhyeinMed Receives Confirmation Of Readiness
(TheNewswire)
Vancouver, B.C. / TheNewswire / March 15, 2018 – HERITAGE CANNABIS HOLDINGS CORPORATION (CSE: CANN) (“Heritage” or “Company”) is pleased to announce that its subsidiary PhyeinMed Inc. (“PhyeinMed”) has received from Health Canada a Confirmation of Readiness (“COR”) for a Licence under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).
Further to receiving the COR and as Phase 1 of construction of PhyeinMed’s Falkland, BC facility nears completion, the team is now preparing the extensive Evidence Package which is necessary to obtain a Production Licence under section 35 of the ACMPR. This package will include documentation, detailed photos and video, facility design packages, and the ability to demonstrate product storage, security, monitoring of access and record keeping.
“We have worked closely with Health Canada throughout this process, and we are excited to have cleared this important milestone on the way to becoming a Licenced Producer” says Debra Senger, PhyeinMed CEO “I am so proud of our team and the work they have done, particularly in the past four months and we are confident our evidence will meet and exceed the requirements in the upcoming review.”
PhyeinMed is a late stage applicant under the ACMPR, and is nearing the completion of Phase 1 of a multi-phase construction project, targeting up to 420,000 sq ft of cannabis grow space in Falkland, BC.
Jagdip Bal, CEO of Heritage states “We are so excited for PhyeinMed to receive such fantastic news. We have a strong team and our sound strategy of being a fast-growing producer of high quality cannabis and cannabis related products in BC, and eventually Ontario. We are looking forward to what we hope will be a speedy process to achieving our Production Licence.”
About Heritage Cannabis Holdings Corporation
The Company is currently listed as a marijuana issuer having a 75% interest in PhyeinMed Inc, a Health Canada late stage applicant under the ACMPR (Access to Cannabis for Medical Purposes Regulations). It is a parent and development company with strategic plans to continue to acquire Cannabis related companies.
ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORPORATION
“Jag Bal”
Jagdip Bal
President and CEO
For more information contact:
Jag Bal
Tel: 604-628-1767
The Canadian Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, the results of exploration activities -- that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Click Image To View Full Size
Copyright (c) 2018 TheNewswire - All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.